Skip to main content

Day: July 14, 2020

Colliers International Group Inc. to Announce Second Quarter Results on August 6, 2020

TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ and TSX: CIGI), announced today that results for the second quarter ended June 30th, 2020 will be issued by press release on Thursday August 6th, 2020 at approximately 7:00am ET.The conference call to review these financial results will take place at 11:00am ET on Thursday August 6th, 2020 and will be hosted by Jay S. Hennick, Chairman & CEO, John Friedrichsen, COO and Christian Mayer, CFO. The numbers to use for this call are: 1) toll-free 1-877-402-8911; or 2) for international callers 1-707-927-4894, with the conference ID number 1587213 for all participants.The conference call will also be accessible on our website at Corporate.Colliers.com in the “Events” section. For anyone unable to listen to the scheduled call, the rebroadcast number...

Continue reading

TOUGHBUILT™ ANNOUNCES INVENTORY BUILD UP IN ANTICIPATION OF MARKET DEMAND FOR PRODUCTS

LAKE FOREST, Calif, July 14, 2020 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt®”) (NASDAQ: TBLT; TBLTW) is an advanced product design, manufacturer and distributor with emphasis on innovative products, currently focused on tools and other accessories for the professional and home improvement building and construction industries.ToughBuilt today announced that it has made plans to build up $10 million in inventory to cover anticipated demand for products internationally and domestically. As previously announced, ToughBuilt has initiated inventory placement in Mexico to service its South American demand, as well as inventory in the Netherlands to cover increased demand from existing sources as well as the newly announced relationships with Toolstation and others in Europe. This international inventory is in addition...

Continue reading

Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update

LA JOLLA, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system and related biological signaling pathways, today reported financial and operating results for the third quarter ended May 31, 2020 of its fiscal year ending August 31, 2020 and provided a business update.“We continue to make meaningful clinical and operational progress throughout our therapeutic product candidate pipeline,” stated Gregory D. Gorgas, Artelo’s President and CEO. “Notably, Artelo was awarded the first and only composition of matter patent for our novel cocrystal of CBD, ART12.11, establishing a basis for market exclusivity through the end of 2038 and supporting our development for PTSD and inflammatory...

Continue reading

Superior Group of Companies Announces Second Quarter 2020 Earnings Conference Call and Webcast

SEMINOLE, Fla., July 14, 2020 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc.® (NASDAQ: SGC) (the “Company”) today announced that it intends to release the results of its operations for the second quarter 2020 before the market opens on Wednesday, July 29, 2020. Michael Benstock, Chief Executive Officer and Andrew D. Demott, Jr., Chief Operating Officer, Chief Financial Officer and Treasurer, will host a teleconference at 10:00 a.m. Eastern Time on that day to discuss the Company’s results and answer appropriate questions.Interested individuals may join the teleconference by dialing (844) 861-5505 for U.S. dialers and (412) 317-6586 for International dialers. The Canadian Toll-Free number is (866) 605-3852. Please ask to be joined into the Superior Group of Companies call. The live webcast and archived replay can also be accessed...

Continue reading

‘The Outpost’ Remains the #1 Movie in America

COS COB, Conn., July 14, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced that Screen Media’s release of Millennium Media’s The Outpost remains the top movie in America for a second straight weekend.The Outpost hit #1 on several VOD platforms since its debut on July 3rd, including on iTunes, GooglePlay, Spectrum and FandangoNOW. It is “Certified Fresh” on Rotten Tomatoes, with a 91% rating.In this military thriller, a tiny unit of U.S. soldiers, alone at the remote Combat Outpost Keating, located deep in the valley of three mountains in Afghanistan, battles to defend against an overwhelming force of Taliban fighters in a coordinated attack. The Battle of Kamdesh, as it was known, was...

Continue reading

The Alkaline Water Company’s A88CBD™ to Launch on Direct CBD Online’s E-Commerce Shop

Prominent high-quality and high volume CBD retailer, Direct CBD Online, will begin selling A88CBD™’s line of CBD topical and ingestible products on their online store.SCOTTSDALE, Ariz., July 14, 2020 (GLOBE NEWSWIRE) — The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the “Company”), a producer of bottled alkaline water, flavor-infused waters, and CBD-infused products sold under the brand names Alkaline88®, A88 Infused™, and A88CBD™, respectively. The Company today announces that A88CBD™’s complete product offerings will be available to purchase at Direct CBD Online—a high-quality CBD retailer—starting this week.“We are thrilled to announce that A88CBD™ is expanding its digital footprint and national presence by launching its complete topical and ingestible product lines on Direct CBD Online’s e-commerce site,” stated Richard...

Continue reading

Iconic Brands Announces Successful Launch of Bellissima Bambinis by Christie Brinkley on QVC®

·       Company sees solid sales during the TV appearances and post-show·       Newly introduced Bellissima Bambinis were a big hit; showcased by Christie Brinkley on her fourth QVC appearance·       Upcoming appearance for Christie Brinkley and Bellissima Bambinis on QVC scheduled for July 15, 2020  Amityville, NY, July 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Iconic Brands, Inc. (ICNB) (“Iconic” or the “Company”), a lifestyle branding company with the highest expertise of developing, from inception to completion, alcohol beverage products for itself and third parties, announced that the feature of Christie Brinkley’s Bellissima Prosecco and Sparkling Wines on a pair of QVC shows was another strong showcase for the brand. Bellissima Bambinis made their grand launch and received much fanfare during the shows, leading...

Continue reading

Gibson Energy Announces Closing of $650 Million Medium Term Note Offering

CALGARY, Alberta, July 14, 2020 (GLOBE NEWSWIRE) — Gibson Energy Inc. (“Gibson” or the “Company”), (TSX: GEI), announced today that it has closed the previously announced offering of $650 million of senior unsecured medium term notes consisting of $325 million of 2.45% notes maturing on July 14, 2025 and $325 million of 2.85% notes maturing on July 14, 2027.  Gibson intends to use the net proceeds from the sale of the notes for the redemption of its outstanding $600 million 5.25% senior unsecured notes due July 15, 2024 (the “2024 Notes”), to reduce outstanding indebtedness under its revolving credit facility and for general corporate purposes.  As a result of the blended coupon rate of the notes being lower than that of the 2024 Notes, following the redemption Gibson expects annualized interest savings of approximately $16 million...

Continue reading

Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors

SYDNEY, Australia, July 14, 2020 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment of Alan W. Dunton, M.D., to its Board of Directors as an independent Non-Executive Director and as a member of the Company’s Audit & Risk and Remuneration & Nomination Committees.“On behalf of all the team at Recce, we welcome Dr. Dunton to our Board of Directors,” stated Dr. John Prendergast, Recce Pharmaceuticals Non-Executive Chairman. “Alan joins us at a critical time as we move into the second half of 2020, where we anticipate a number of human clinical trials evaluating our broad-spectrum novel antibiotic, RECCE® 327. In addition, we will continue to investigate the efficacy of our synthetic compounds against SARS-CoV-2...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.